Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to explain the comparison of core stabilization strength and pelvic floor functions between individuals diagnosed with Sjogren syndrome and a healthy control group.
(Sjogren syndrome group n=27; control group n=27)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control group | The control group will consist of healthy volunteers. |
| |
| Sjogren syndrome | The Sjogren syndrome group will consist of patients aged between 18-65 who apply to the Rheumatology Department of Pamukkale University and meet the inclusion criteria. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Core Muscle testing and patient reported outcome measures | Other | These are the situation evaluation parameters. It presents the data of the participants at the time of evaluation. |
| Measure | Description | Time Frame |
|---|---|---|
| Pelvic Floor Distress Inventory-20 (PTDE-20) | There are 20 questions in total on the scale. The best score that can be obtained from the entire survey is "0" and the worst score is "300". | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Sexual Life Quality Scale- Women (CYKÖ-K) | The maximum score that can be obtained from the scale with this system is 108. | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Incontinence Impact Questionnaire (IIQ-7) (IES) | Consists of 7 items. Maximum score is 100. | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| The McGill trunk muscle endurance test | The McGill trunk muscle endurance test is a test group that includes all trunk flexor, extensor and lateral muscle endurance tests. | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Measure | Description | Time Frame |
|---|---|---|
| Health assessment questionnaire (HAQ) | This questionnaire consists of 20 questions and 8 subheadings, each answer ranging from 0 to 3 points. | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Cognitive Exercise Therapy Approach (BETY) |
Not provided
Inclusion Criteria:
Sjogren syndrome group:
Control group:
-Being 18 years of age or older,
Exclusion Criteria:
Sjogren syndrome group and control group:
Not provided
Sjogren syndrome group and control group
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pamukkale Üniversitesi | Denizli | Denizli | 20000 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41538013 | Derived | Akar B, Kabul EG, Calik BB, Bozcuk S, Cobankara V. Investigation of Core Stabilization Strength and Pelvic Floor Functions in Patients with Primary Sjogren's Syndrome: A Case-Control Study. Int Urogynecol J. 2026 Jun;37(6):1641-1652. doi: 10.1007/s00192-025-06467-6. Epub 2026 Jan 15. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012859 | Sjogren's Syndrome |
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000071066 | Patient Reported Outcome Measures |
| ID | Term |
|---|---|
| D019538 | Health Care Surveys |
| D011795 | Surveys and Questionnaires |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
Not provided
Not provided
Not provided
Not provided
Not provided
This scale has 30 items. The scale is scored with a 5-point Likert system. |
| Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| D012216 |
| Rheumatic Diseases |
| D014987 | Xerostomia |
| D012466 | Salivary Gland Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D015352 | Dry Eye Syndromes |
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D008919 |
| Investigative Techniques |
| D006302 | Health Services Research |
| D006285 | Health Planning |
| D004472 | Health Care Economics and Organizations |
| D063868 | Patient Outcome Assessment |
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
| D017531 | Health Care Evaluation Mechanisms |
| D011634 | Public Health |
| D004778 | Environment and Public Health |